Pharma M&A down to near 5 year low
Deals in 2017 are on pace for almost half the yearly totals of the past two years. Potential buyers await clarity surrounding tax reform.

Deals in 2017 are on pace for almost half the yearly totals of the past two years. Potential buyers await clarity surrounding tax reform.